HomeDOSE • CNSX
add
Rapid Dose Therapeutics Corp
Previous close
$0.18
Day range
$0.19 - $0.19
Year range
$0.13 - $0.33
Market cap
24.61M CAD
Avg Volume
41.92K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Nov 2024info | Y/Y change |
|---|---|---|
Revenue | 501.69K | 114.57% |
Operating expense | 1.29M | 39.23% |
Net income | -1.36M | -39.08% |
Net profit margin | -271.98 | 35.18% |
Earnings per share | — | — |
EBITDA | -968.57K | -50.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Nov 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 40.10K | -75.87% |
Total assets | 1.67M | -16.23% |
Total liabilities | 5.77M | -11.58% |
Total equity | -4.10M | — |
Shares outstanding | 128.44M | — |
Price to book | -6.00 | — |
Return on assets | -150.08% | — |
Return on capital | 192.45% | — |
Cash Flow
Net change in cash
| (CAD) | Nov 2024info | Y/Y change |
|---|---|---|
Net income | -1.36M | -39.08% |
Cash from operations | -266.40K | 60.40% |
Cash from investing | — | — |
Cash from financing | 234.82K | -63.04% |
Net change in cash | -31.58K | 15.21% |
Free cash flow | -161.82K | 52.91% |
About
Founded
2008
Headquarters
Website
